Veraxa Biotech Holding Stock (NASDAQ:VRXA)
Previous Close
$2.48
52W Range
$1.70 - $27.36
50D Avg
$9.34
200D Avg
$10.51
Market Cap
$311.10M
Avg Vol (3M)
$361.95K
Beta
0.25
Div Yield
-
VRXA Company Profile
Veraxa Biotech Holding AG is a clinical-stage biopharmaceutical company, formed via a merger with Voyager Acquisition Corp., focusing on developing next-generation cancer therapies such as antibody-drug conjugates (ADCs) and bispecific T-cell engagers. [64, 65]